There are 116 resources available
Patient Management Considerations in HR+/HER2− Early Breast Cancer
Presenter: Peter A. Fasching
Session: Novartis - The Evolution of HR+/HER2− Early Breast Cancer Clinical Practice: Broadening the Impact of CDK4/6 Inhibitors
Resources:
Webcast
Expert perspectives: optimising care for patients receiving DLL3 T-cell engagers
Presenter: Maurice Pérol
Session: Amgen - Innovation in lung cancer treatment: unlocking the potential of precision medicine
Resources:
Webcast
Raising the Bar: Optimizing Curative Opportunities in Early HCC
Presenter: Stephen Chan
Session: Medscape Global Oncology - Milestones and Horizons in Hepatobiliary Carcinomas: The Unfolding Story of Immunotherapy
Resources:
Webcast
Treatment experience matters: integration of subcutaneous immunotherapy in the clinic
Presenter: Margarita Majem, Jarushka Naidoo
Session: F. Hoffmann - La Roche - Patient Matters: Innovation in Lung Cancer
Resources:
Webcast
HR-Positive Metastatic Breast Cancer: The Latest Updates and Clinical Implications of HER2- and TROP2-Directed ADCs
Presenter: Aditya Bardia
Session: PeerVoice - Staying at the Forefront of HER2- and TROP2-Directed Antibody-Drug Conjugate (ADC) Advances in Breast Cancer
Resources:
Webcast
Looking Forward: Chemotherapy De-Escalation and Sparing Trials, Closing and Q&A
Presenter: César A. Rodríguez, Peter A. Fasching, Sara Tolaney
Session: Novartis - The Evolution of HR+/HER2− Early Breast Cancer Clinical Practice: Broadening the Impact of CDK4/6 Inhibitors
Resources:
Webcast
Advancing lung cancer treatment: emerging targets and novel therapies
Presenter: Ernest Nadal
Session: Amgen - Innovation in lung cancer treatment: unlocking the potential of precision medicine
Resources:
Webcast
Maximizing Potential: Integrating Immunotherapy into the Management of BTC
Presenter: Arndt Vogel
Session: Medscape Global Oncology - Milestones and Horizons in Hepatobiliary Carcinomas: The Unfolding Story of Immunotherapy
Resources:
Webcast
Panel discussion and Q&A
Presenter: Ben Solomon, Fernando Lopez-Rios, Jarushka Naidoo, Margarita Majem
Session: F. Hoffmann - La Roche - Patient Matters: Innovation in Lung Cancer
Resources:
Webcast
ADCs for High-Risk Early HER2-Positive Breast Cancer: Are the Data Showing Potential?
Presenter: Peter Schmid, Cristina Saura Manich, Aditya Bardia
Session: PeerVoice - Staying at the Forefront of HER2- and TROP2-Directed Antibody-Drug Conjugate (ADC) Advances in Breast Cancer
Resources:
Webcast